Spear Therapeutics Limited
Records under this name other than patents Spear Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Spear Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,214,886 | Hydroxylation activated prodrugs Term ended Term ended Jul 14, 2018 · USPTO record | Term ended | Term ended Jul 14, 2018 | USPTO record |
| US 6,346,550 | Hydroxylation activated prodrugs Formerly held Term ended Term ended Jul 14, 2018 · USPTO record | Term ended | Term ended Jul 14, 2018 | USPTO record |
| US 6,677,383 | Hydroxylation activated prodrugs Term ended Term ended Jul 14, 2018 · USPTO record | Term ended | Term ended Jul 14, 2018 | USPTO record |
| US 7,598,294 | 3, 4-Methylenedioxy-SUBSTITUTED Chalcones as Therapeutic Agents Lapsed on the fee record Ended Oct 6, 2017 · High confidence | Lapsed on the fee record | Ended Oct 6, 2017 | High confidence |
| US 6,794,384 | Hydroxylation activated drug release Lapsed on the fee record Ended Sep 21, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2016 | USPTO record |
| US 6,787,672 | Substituted Chalcones as Therapeutic Compounds Lapsed on the fee record Ended Sep 7, 2016 · High confidence | Lapsed on the fee record | Ended Sep 7, 2016 | High confidence |
| US 8,236,827 | Compounds Lapsed on the fee record Ended Aug 7, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 7, 2016 | USPTO record |
| US 7,112,698 | 4-(C2-6ALKOXY)-SUBSTITUTED Chalcones as Therapeutic Agents Lapsed on the fee record Ended Sep 26, 2014 · High confidence | Lapsed on the fee record | Ended Sep 26, 2014 | High confidence |